image1701
  • Home
  • About Us
  • VirIntel COVID-19 Test
  • Science and Technology
  • Partner with Us
  • Support
  • Virintel In the News
  • More
    • Home
    • About Us
    • VirIntel COVID-19 Test
    • Science and Technology
    • Partner with Us
    • Support
    • Virintel In the News
image1702
  • Home
  • About Us
  • VirIntel COVID-19 Test
  • Science and Technology
  • Partner with Us
  • Support
  • Virintel In the News

Press Releases

VirIntel launches VirIntel COVID-19 Antibody test, delivering superior accuracy

  Sep 2020 Gaithersburg, MD

VirIntel, LLC is the R&D focused Immuno diagnostics startup located at the Frederick Innovation Technology Center pursuing the goal of immunity intelligence. VirIntel is leading the charge on the “know your immunity” movement in response to COVID-19.

About COVID-19 Testing at VirIntel

VirIntel, LLC has developed and commercialized a COVID-19 antibody test with demonstrated 100% specificity and 94% sensitivity in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection. The VirIntel COVID-19 Antibody Test measures antibodies against two viral proteins, a receptor-binding domain (RBD) of spike glycoprotein and nucleocapsid protein N, thus decreasing and eliminating false positive results. RBD is considered to be the primary target for neutralizing antibodies against SARS-CoV-2. Neutralizing antibodies inhibit infection of human cells by SARS-CoV-2. 

Dr. Maria Kireeva, head scientist at VirIntel comments: “We designed our dual-antigen test to ensure the best possible specificity without loss in the sensitivity of the test. Furthermore, this is part of our broader approach to developing tests that measure antibodies against multiple viral proteins and antigens as the means to evaluate the level of protection offered by the immune system.”

The VirIntel COVID-19 Antibody Test requires a blood draw at the point of care and the results can be analyzed by any laboratory certified under the Clinical Laboratory Improvement Amendments (CLIA), a federal government standard for ensuring quality laboratory testing of humans. 

The test is not available for home testing. 

About VirIntel, LLC

VirIntel is a privately-held biotechnology company pursuing the goal of immunity intelligence. VirIntel and its executive team have a successful track record of partnerships with global companies interested in developing and commercializing companion diagnostics, and provides expertise in both regulatory and laboratory services.

To learn more please visit: www.virintel.com 

Leading the charge on ‘Know your Immunity,’ VirIntel, LLC announces a partnership with Clinical D

  

October 6  2020 Gaithersburg, MD

VirIntel, LLC is excited to announce a partnership with Clinical Diagnostic Laboratories (CDL), one of the top Diagnostics Lab in the DC metro area, to offer the VirIntel COVID-19 Antibody Test available immediately. 

VirIntel leads the charge on the "know your immunity" movement in response to COVID-19 and has developed and commercialized a COVID-19 antibody test with demonstrated 100% specificity and 94% sensitivity in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection. 

Ibtihaj Awdelkariem, MLS, CDL Technical Director, comments: "We want to offer an antibody test to our customers that is very accurate and delivers results quickly. The VirIntel COVID-19 Antibody Test has superior accuracy, and we can deliver the results ready 48 hours."

The VirIntel COVID-19 Antibody Test requires a blood draw at the point of care and is not currently available for home testing. 

About Clinical Diagnostics Laboratories (CDL)

CDL is an independent, full-service, clinical laboratory directed by a board-certified pathologist and qualified expert technologists. Our Medical Director is nationally recognized as a specialist in laboratory medicine. We are a group of dedicated, experienced, and qualified personnel who are committed to providing the highest quality service through advanced   

technology and personal attention. However, we take pride in our efforts to expand the scope and improve our testing services' quality through the addition of state-of-the-art equipment. We stand by the dictum that behind every sample is a patient, and every patient is a unique individual.

CDL provides a broad range of services, including testing performed on automated laboratory equipment that allows for positive patient ID with barcode technology. Since we are a local laboratory, patient testing is done as soon as it is brought to the lab, which greatly increases the turnaround time and maintains the specimens' integrity. As an Immediate Response Laboratory, we provide STAT and general laboratory testing for our patients. CDL Provides quality work for patients and continually strives to improve services to meet our patients' needs. We provide testing in the following specialties: Hematology, Chemistry, Endocrinology, Urinalysis, and Microbiology. 

About VirIntel, LLC
VirIntel, LLC is a privately held, R & D-driven biotechnology company developing a portfolio of Immuno-diagnostic tools to pursue immunity intelligence. They are located at the Frederick Innovation Technology Center. Leading the charge on the “know your immunity” movement in response to COVID-19, VirIntel recently commercialized its first product, the VirIntel COVID-19 Antibody Test. VirIntel and its executive team have a successful track record of partnerships  with global companies interested in developing and commercializing companion diagnostics and providing expertise in regulatory and laboratory services.   

Copyright © 2020 Coronavirus Immunity Diagnostics - All Rights Reserved.

  • Contact Us